• Loading stock data…

CORRECTION — Arcutis Announces Positive Topline Results from INTEGUMENT-1 Pivotal Phase 3 Trial of Roflumilast Cream in Atopic Dermatitis in Adults and Children Aged Six Years and Older

Last Updated on November 15, 2022 by GlobeNewsWire

CORRECTION: In a press release issued earlier today under the same headline, please note that the p-value for WI-NRS should have been P<0.01 not P<0.0001.




Print Friendly, PDF & Email
Spread the word

Reader Interactions

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: